Public Company

Genflow Biosciences PLC

Driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.


Glenflow is a UK based biotech company dedicated to the development and commercialization of novel therapeutics targeting aging in dogs and humans. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has shown promising preclinical results.


Founded 2020
Type Public
Longevity related Yes
Location United Kingdom, UK